Alzheimer’s drugs currently being denied to some NHS patients may have a dramatic impact on the pathology of the brain, research in the UK indicates. Neurology says that post-mortem tests on 24 patients found a 70% fall of a protein linked to dementia in those who had taken cholinesterase inhibitors. >>> Discuss This Story
